Home > Insider Trading > Filing (0000950103-20-015373)

Filing Details

Accession Number:: 0000950103-20-015373
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-05 21:50:53
Reporting Period:: 2020-08-03

Accepted Time:: 2020-08-05 21:50:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642545	Shockwave Medical Inc.	SWAV	()	I0

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1616320	Fcpr Vii Capital Sofinnova	C/O Shockwave Medical, Inc. 5403 Betsy Ross Drive Santa Clara CA 95054		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-08-03	85,549	$50.01	2,748,547	No	4	S	Direct
Common Stock	Disposition	2020-08-04	33,323	$50.01	2,715,224	No	4	S	Direct
Common Stock	Disposition	2020-08-05	73,860	$50.46	2,641,364	No	4	S	Direct
Common Stock	Disposition	2020-08-05	35,546	$51.23	2,605,818	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares held by the reporting person are also reported on Form 4 by Antoine Papiernik, one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of the reporting person. Mr. Papiernik disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $50.00 to $50.12. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $50.00 to $50.10. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $50.00 to $50.9961. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $51.00 to $51.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.